All the news Showing 10 of 82 articles from: Protease inhibitorsGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources New hep C treatments set to overturn US market, says study PharmaTimes / 28 November 2013 FDA approves new treatment for hepatitis C virus FDA / 26 November 2013 AbbVie Releases First of Six Phase III Results from Investigational All-Oral, Interferon-Free, 12-week Regimen, Showing 96 Percent SVR12 in Genotype 1 Hepatitis C Patients New to Therapy AbbVie press release / 18 November 2013 Costs for Hepatitis C Treatment Skyrocket Medscape (requires registration) / 14 November 2013 Immunosuppression, EVR predictive of SVR in liver transplant recipients with HCV Healio Hepatology / 08 November 2013 Boehringer Ingelheim's interferon-free hepatitis C treatment portfolio strengthened by promising Phase II data Boehringer Ingelheim press release / 03 November 2013 High cure rates seen with Merck oral hepatitis drugs - study Reuters / 03 November 2013 Bristol seeks Japan approval of all-oral hepatitis C treatment Yahoo News / 02 November 2013 US FDA approves twice-daily dosing for telaprevir (Incivek) FDA / 31 October 2013 FDA Panel Recommends Approval of Simeprevir for Hepatitis C Medscape (requires free registration) / 25 October 2013 ← Prev1...34567...9Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive